Pharma companies need to revisit their supply chains to be able to respond to the industry’s future needs.
Listen to Steve Arlington discuss the key highlights from Pharma 2020
The sixth paper in the Pharma 2020 series highlights how pharma companies will have to develop different supply chain models for different product types and patient segments and learn to use their supply chains as a means of market differentiation and source of economic value.